• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期口服西洛他唑停药后血小板功能的恢复

Recovery of platelet function after withdrawal of cilostazol administered orally for a long period.

作者信息

Iwamoto Toshihiko, Kin Kyoko, Miyazaki Kaori, Shin Kouichi, Takasaki Masaru

机构信息

Department of Geriatric Medicine, Tokyo Medical University Hospital, Tokyo, Japan.

出版信息

J Atheroscler Thromb. 2003;10(6):348-54. doi: 10.5551/jat.10.348.

DOI:10.5551/jat.10.348
PMID:15037824
Abstract

To clarify the recovery of platelet function after abrupt withdrawal of cilostazol, we studied platelet function and cilostazol concentration in elderly who received cilostazol, 100 mg twice a day (200 mg/day), for a long period. After interviewing the time of final cilostazol intake, platelet aggregability was determined with an aggregometer using four different concentrations of adenosine-5'-diphosphate as an inducer, which showed the grading curve (GC) type and platetet aggregatory threshold index (PATI). Serum cilostazol concentration was also determined by high-performance liquid chromatography. The GC type and PATI showed suppressed platelet function until 15 hours after withdrawal in half of patients. Bleeding time measured by the Simplate method was prolonged within 4 hours, but recovered by 12 hours after the withdrawal. Some serum cilostazol concentrations were still high 15 hours after withdrawal, while platelets were inhibited even in patients with low serum concentration of cilostazol. In the group receiving the drug for less than 6 months, PATI correlated with serum cilostazol concentration, but platelets in the long-term administration group (more than 48 months) were suppressed at the low serum cilostazol concentration. These findings indicated that platelet function recovered within 12-16 hours after withdrawal in these patients.

摘要

为明确突然停用西洛他唑后血小板功能的恢复情况,我们对长期每日两次服用西洛他唑100mg(200mg/天)的老年患者的血小板功能和西洛他唑浓度进行了研究。在询问末次服用西洛他唑的时间后,使用聚集仪以四种不同浓度的5'-二磷酸腺苷作为诱导剂测定血小板聚集性,得出分级曲线(GC)类型和血小板聚集阈值指数(PATI)。血清西洛他唑浓度也通过高效液相色谱法测定。半数患者的GC类型和PATI显示,停药后15小时内血小板功能受到抑制。用Simplate法测定的出血时间在停药后4小时内延长,但在停药后12小时恢复。停药15小时后,部分患者血清西洛他唑浓度仍较高,而即使在血清西洛他唑浓度较低的患者中,血小板也受到抑制。在服药时间少于6个月的组中,PATI与血清西洛他唑浓度相关,但在长期给药组(超过48个月)中,低血清西洛他唑浓度时血小板仍受到抑制。这些发现表明,这些患者停药后12 - 16小时内血小板功能恢复。

相似文献

1
Recovery of platelet function after withdrawal of cilostazol administered orally for a long period.长期口服西洛他唑停药后血小板功能的恢复
J Atheroscler Thromb. 2003;10(6):348-54. doi: 10.5551/jat.10.348.
2
Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method.通过筛滤压力法,使用新型全血凝集仪评估抗血小板药物对人血小板聚集的影响。
Br J Pharmacol. 2001 Aug;133(8):1396-404. doi: 10.1038/sj.bjp.0704204.
3
Cilostazol and dipyridamole synergistically inhibit human platelet aggregation.西洛他唑和双嘧达莫协同抑制人血小板聚集。
J Cardiovasc Pharmacol. 2004 Aug;44(2):266-73. doi: 10.1097/00005344-200408000-00017.
4
Platelet aggregometry in the presence of PGE(1) provides a reliable method for cilostazol monitoring.在 PGE(1)存在的情况下进行血小板聚集测定,为监测西洛他唑提供了一种可靠的方法。
Thromb Res. 2012 Oct;130(4):616-21. doi: 10.1016/j.thromres.2012.05.030. Epub 2012 Jun 22.
5
Combined aspirin and cilostazol treatment is associated with reduced platelet aggregation and prevention of exercise-induced platelet activation.阿司匹林与西洛他唑联合治疗可降低血小板聚集,并预防运动诱导的血小板活化。
Eur J Vasc Endovasc Surg. 2009 May;37(5):604-10. doi: 10.1016/j.ejvs.2009.01.008. Epub 2009 Mar 17.
6
Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.在急性心肌梗死患者中,添加西洛他唑进行双联抗血小板治疗比高维持剂量氯吡格雷实现更大的血小板抑制:辅助性西洛他唑与急性心肌梗死患者高维持剂量氯吡格雷(ACCEL-AMI)研究的结果。
Circ Cardiovasc Interv. 2010 Feb 1;3(1):17-26. doi: 10.1161/CIRCINTERVENTIONS.109.880179. Epub 2010 Jan 26.
7
Platelet inhibition by adjunctive cilostazol versus high maintenance-dose clopidogrel in patients with acute myocardial infarction according to cytochrome P450 2C19 genotype.根据细胞色素 P450 2C19 基因型,急性心肌梗死患者中联合西洛他唑与高维持剂量氯吡格雷的血小板抑制作用。
JACC Cardiovasc Interv. 2011 Apr;4(4):381-91. doi: 10.1016/j.jcin.2010.12.010.
8
Cilostazol down-regulates the height of mural platelet thrombi formed under a high-shear rate flow in the absence of ADAMTS13 activity.西洛他唑可下调在缺乏 ADAMTS13 活性的高剪切率血流下形成的壁面血小板血栓的高度。
Eur J Pharmacol. 2012 Sep 15;691(1-3):151-5. doi: 10.1016/j.ejphar.2012.07.001. Epub 2012 Jul 13.
9
Pharmacokinetic and pharmacodynamic modeling of the antiplatelet and cardiovascular effects of cilostazol in healthy humans.西洛他唑在健康人体中的抗血小板和心血管效应的药代动力学和药效学建模。
Clin Pharmacol Ther. 2002 Apr;71(4):246-52. doi: 10.1067/mcp.2002.122474.
10
Inhibition of platelet aggregation by combined therapy with aspirin and cilostazol after off-pump coronary artery bypass surgery.非体外循环冠状动脉搭桥术后阿司匹林与西洛他唑联合治疗对血小板聚集的抑制作用。
Ann Thorac Cardiovasc Surg. 2008 Aug;14(4):230-7.

引用本文的文献

1
Antiplatelet Therapy for Atherothrombotic Disease in 2022-From Population to Patient-Centered Approaches.2022年动脉粥样硬化血栓形成性疾病的抗血小板治疗——从群体到以患者为中心的方法
Front Cardiovasc Med. 2022 Jan 28;9:805525. doi: 10.3389/fcvm.2022.805525. eCollection 2022.
2
Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases.当前和新型抗血小板治疗心血管疾病。
Int J Mol Sci. 2021 Dec 3;22(23):13079. doi: 10.3390/ijms222313079.
3
Anti-platelet therapy: phosphodiesterase inhibitors.抗血小板治疗:磷酸二酯酶抑制剂。
Br J Clin Pharmacol. 2011 Oct;72(4):634-46. doi: 10.1111/j.1365-2125.2011.04034.x.